Myriad Genetics (NASDAQ:MYGN) Lowered to “Hold” Rating by StockNews.com
StockNews.com lowered shares of Myriad Genetics (NASDAQ:MYGN – Free Report) from a buy rating to a hold rating in a research report sent to investors on Thursday morning. Other equities analysts have also recently issued reports about the stock. Leerink Partnrs cut shares of Myriad Genetics from a “strong-buy” rating to a “hold” rating in […]
StockNews.com lowered shares of Myriad Genetics (NASDAQ:MYGN – Free Report) from a buy rating to a hold rating in a research report sent to investors on Thursday morning. Other equities analysts have also recently issued reports about the stock. Leerink Partnrs cut shares of Myriad Genetics from a “strong-buy” rating to a “hold” rating in […]
